Cargando…

Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection

BACKGROUND: To examine the clinical features of acute acquired comitant esotropia (AACE) and to evaluate the clinical effectiveness of a single injection of botulinum toxin type A (BTXA) on binocular visual function (BVF). METHODS: This retrospective, observational case series study enrolled patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Luyao, Yu, Xiaoning, Tang, Xiajing, Zhang, Yidong, Zheng, Sifan, Sun, Zhaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689961/
https://www.ncbi.nlm.nih.gov/pubmed/33238930
http://dx.doi.org/10.1186/s12886-020-01739-9
_version_ 1783613970373935104
author Tong, Luyao
Yu, Xiaoning
Tang, Xiajing
Zhang, Yidong
Zheng, Sifan
Sun, Zhaohui
author_facet Tong, Luyao
Yu, Xiaoning
Tang, Xiajing
Zhang, Yidong
Zheng, Sifan
Sun, Zhaohui
author_sort Tong, Luyao
collection PubMed
description BACKGROUND: To examine the clinical features of acute acquired comitant esotropia (AACE) and to evaluate the clinical effectiveness of a single injection of botulinum toxin type A (BTXA) on binocular visual function (BVF). METHODS: This retrospective, observational case series study enrolled patients with AACE examined from October 2018–May 2019. BTXA was injected into the both medial rectus muscles. The refractive error, best-corrected visual acuity (BCVA), stereoacuity, vergence, accommodation, the horizontal angle of deviation, and the gradient accommodative convergence/accommodation (AC/A) ratio were measured pre- and post-BTXA injection. Data pre- and postinjection were compared by the Wilcoxon signed-rank test. A Spearman correlation coefficient was calculated to explore the relationships between demographic characteristics and BVF. RESULTS: Twenty-two AACE cases were included. Compared with preinjection deviation, the postinjection deviation in the primary position was smaller for near (p < 0.001) and distance (p < 0.001) fixation at 3 months after injection (BTXA). Furthermore, convergence was better for near (p = 0.003) and distance (p < 0.001) fixation, divergence was better for near (p = 0.021) and distance (p < 0.001) fixation, accommodation was better in the right (p = 0.011) and left (p = 0.004) eyes, and the gradient AC/A ratio was better at the third month after injection (p = 0.001). Stereoacuity was improved in 11 (50%), unchanged in 5 (22.73%) and decreased in 6 (27.27%) patients. The preinjection stereoacuity (p = 0.013, r = 0.522) and preinjection deviation for near (p = 0.015 r, = − 0.512) and distance (p = 0.009, r = − 0.541) were significantly associated with patient age. CONCLUSIONS: AACE is characterized by a high AC/A ratio and low accommodation. A single injection of BTXA is effective for AACE. Deviation, stereoacuity, and the therapeutic effect of BTXA may be correlated with patient age.
format Online
Article
Text
id pubmed-7689961
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76899612020-11-30 Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection Tong, Luyao Yu, Xiaoning Tang, Xiajing Zhang, Yidong Zheng, Sifan Sun, Zhaohui BMC Ophthalmol Research Article BACKGROUND: To examine the clinical features of acute acquired comitant esotropia (AACE) and to evaluate the clinical effectiveness of a single injection of botulinum toxin type A (BTXA) on binocular visual function (BVF). METHODS: This retrospective, observational case series study enrolled patients with AACE examined from October 2018–May 2019. BTXA was injected into the both medial rectus muscles. The refractive error, best-corrected visual acuity (BCVA), stereoacuity, vergence, accommodation, the horizontal angle of deviation, and the gradient accommodative convergence/accommodation (AC/A) ratio were measured pre- and post-BTXA injection. Data pre- and postinjection were compared by the Wilcoxon signed-rank test. A Spearman correlation coefficient was calculated to explore the relationships between demographic characteristics and BVF. RESULTS: Twenty-two AACE cases were included. Compared with preinjection deviation, the postinjection deviation in the primary position was smaller for near (p < 0.001) and distance (p < 0.001) fixation at 3 months after injection (BTXA). Furthermore, convergence was better for near (p = 0.003) and distance (p < 0.001) fixation, divergence was better for near (p = 0.021) and distance (p < 0.001) fixation, accommodation was better in the right (p = 0.011) and left (p = 0.004) eyes, and the gradient AC/A ratio was better at the third month after injection (p = 0.001). Stereoacuity was improved in 11 (50%), unchanged in 5 (22.73%) and decreased in 6 (27.27%) patients. The preinjection stereoacuity (p = 0.013, r = 0.522) and preinjection deviation for near (p = 0.015 r, = − 0.512) and distance (p = 0.009, r = − 0.541) were significantly associated with patient age. CONCLUSIONS: AACE is characterized by a high AC/A ratio and low accommodation. A single injection of BTXA is effective for AACE. Deviation, stereoacuity, and the therapeutic effect of BTXA may be correlated with patient age. BioMed Central 2020-11-25 /pmc/articles/PMC7689961/ /pubmed/33238930 http://dx.doi.org/10.1186/s12886-020-01739-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Tong, Luyao
Yu, Xiaoning
Tang, Xiajing
Zhang, Yidong
Zheng, Sifan
Sun, Zhaohui
Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title_full Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title_fullStr Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title_full_unstemmed Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title_short Functional acute acquired comitant esotropia: clinical characteristics and efficacy of single Botulinum toxin type A injection
title_sort functional acute acquired comitant esotropia: clinical characteristics and efficacy of single botulinum toxin type a injection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689961/
https://www.ncbi.nlm.nih.gov/pubmed/33238930
http://dx.doi.org/10.1186/s12886-020-01739-9
work_keys_str_mv AT tongluyao functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection
AT yuxiaoning functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection
AT tangxiajing functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection
AT zhangyidong functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection
AT zhengsifan functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection
AT sunzhaohui functionalacuteacquiredcomitantesotropiaclinicalcharacteristicsandefficacyofsinglebotulinumtoxintypeainjection